Board approves Q3-Q9 unaudited results, appoints an Independent Director, approves a ₹66 crore stake in Garuda Renewables for renewable energy, and advances a merger scheme between Auro Vaccines and Curateq Biologics; a director’s tenure ends with appreciation.